Antisense oligonucleotides for central nervous system tumors

Neurosurgery

Volumn 38, Issue 2, 1996, Pages 376-383

  Hall, Walter A ^a   Flores, Eric P ^a   Low, Walter C ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Brain neoplasm; Gene therapy; Nucleic acids; Oncogene

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; GENE THERAPY; HUMAN; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

CENTRAL NERVOUS SYSTEM NEOPLASMS; GENE THERAPY; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENES;

EID: 0030033136     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199602000-00029     Document Type: Article

References (24)

1. Ahmed S, Mineta T, Martuza RL, Glazer RI: Antisense expression of protein kinase Cα inhibits the growth and tumorigenicity of human glioblastoma cells. Neurosurgery 35:904-909, 1994.
2. Behl C, Winkler J, Bogdahn U, Meixensberger J, Schligensiepen K-H, Brysch W: Autocrine growth regulation in neuroectodermal tumors as detected with oligodeoxynucleotide antisense molecules. Neurosurgery 33:679-684, 1993.
3. Calabretta B, Skorski T, Szczylik C, Zon G: Prospects for gene-directed therapy with antisense oligodeoxynucleotides. Cancer Treat Rev 19:169-179, 1993.
4. Calabretta B, Skorski T, Zon G: Antisense oligonucleotides. Cancer Biol 3:391-398, 1992.
5. Carter G, Lemoine NR: Antisense technology for cancer therapy: Does it make sense? Br J Cancer 67:869-876, 1993.
6. Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G, Calabretta B: Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A 89:7031-7035, 1992.
7. Cohen JS: Biochemical therapy: Antisense compounds, in Devita VT Jr, Hellman S, Rosenberg SA (eds): Biologic Therapy of Cancer. Philadelphia, J.B. Lippincott Co., 1991, pp 763-775.
8. Flores EP, Chiang L, Wen DYK, Low WC, Hall WA: Suppression of human medulloblastoma cell proliferation with antisense oligonucleotides to the c-myb oncogene. Soc Neurosci Abstr 20:835, 1994 (abstr).
9. Hall WA, Fodstad Ø: Immunotoxins and central nervous system neoplasia. J Neurosurg 76:1-12, 1992.
10. 2-specific phosphorothioateanti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J Neurosurg 78:944-951, 1993.
11. Leonetti JP, Degols G, Clarenc P, Mechti N, Lebleu B: Cell delivery and mechanisms of action of antisense oligonucleotides. Prog Nucleic Acid Res Mol Biol 44:143-166, 1993.
12. Morrison RS: Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266:728-734, 1991.
13. Murphy PR, Sat Y, Knee RS: Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol Endocrinol 6:877-884, 1992.
14. Nitta T, Sato K: Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells. Neurosurgery 34:309-315, 1994.
15. Raschella G, Negroni A, Skorski T, Pucci S, Nieborowska-Skorska M, Romeo A, Calabretta B: Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines. Cancer Res 52:4221-4226, 1992.
16. Redekop GJ, Naus CCG: Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. J Neurosurg 82:83-90, 1995.
17. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R: Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 54:2218-2222, 1994.
18. Rothenberg M, Johnson G, Laughlin C, Green I, Cradock J, Sarver N, Cohen JS: Oligodeoxynucleotides as anti-sense inhibitors of gene expression: Therapeutic implications. J Natl Cancer Inst 81:1539-1544, 1989.
19. Stein CA, Cheng Y-C: Antisense oligonucleotides as therapeutic agents: Is the bullet really magical? Science 261:1004-1012, 1993.
20. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J, Ilan J: Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci U S A 89:4874-4878, 1992.
21. Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML, Ilan J: Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 259:94-97, 1993.
22. Weinstein DE, Shelanski ML, Liem RKH: Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112:1205-1213, 1991.
23. Welter C, Henn W, Theisinger B, Fischer H, Zang KD, Blin N: The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines. Cancer Lett 52:57-62, 1990.
24. Yu ACH, Lee YL, Eng LF: Inhibition of GFAP synthesis by antisense RNA in astrocytes. J Neurosci Res 30:72-79, 1991.